Michael H. Davidson's Net Worth
$7.28 Million
Who is Michael H. Davidson?
Michael H. Davidson has an estimated net worth of $7.28 Million. This is based on reported shares across multiple companies, which include Omthera Pharmaceuticals, Inc., TENAX THERAPEUTICS, INC., and Caladrius Biosciences, Inc..
SEC CIK
Michael H. Davidson's CIK is 0001573785
Past Insider Trading and Trends
2021 was Michael H. Davidson's most active year for acquiring shares with 3 total transactions. Michael H. Davidson's most active month to acquire stocks was the month of May. 2013 was Michael H. Davidson's most active year for disposing of shares, totalling 3 transactions. Michael H. Davidson's most active month to dispose stocks was the month of June. 2020 saw Michael H. Davidson paying a total of $219,943.05 for 106,588 shares, this is the most they've acquired in one year. In 2013 Michael H. Davidson cashed out on 1,557,843 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Omthera Pharmaceuticals, Inc. No price found
Executive VP & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.49M |
—
|
—
|
0
|
Jul 18
| |||
Form 4
| +5.69% | 51.96K |
—
|
—
| 964.59K |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TENAX THERAPEUTICS, INC. (TENX) Snapshot price: $11.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +540.97% | 512K |
—
|
—
| 606.64K |
Jun 10 - Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caladrius Biosciences, Inc. (LSTA) Snapshot price: $2.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.34% | 65.43K |
—
|
—
| 209.75K |
Jan 10
| |||
Form 4
| +35.40% | 37.73K |
—
|
—
| 144.32K |
Jan 11
| |||
Form 4
| +108.74% | 55.52K |
$1.80 | $99,945.00 | 106.59K |
Sep 9
| |||
Form 4
|
∞
| 51.06K |
$2.35 | $119,998.05 | 51.06K |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NewAmsterdam Pharma Co N.V. (NAMS) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||